Search - tctmd.com

Displaying 1 - 20 of 133

Sort: Relevancy | Date

News Daily News

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Yael L. Maxwell

August 14, 2025

News Daily News

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Yael L. Maxwell

June 09, 2025

News Daily News

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

L.A. McKeown

March 06, 2025

News Daily News

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

Yael L. Maxwell

January 23, 2025

News Daily News

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

Yael L. Maxwell

November 27, 2024

News Daily News

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

Michael O'Riordan

September 24, 2024

News Conference News ESC 2024

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

Michael O'Riordan

September 17, 2024

News Daily News

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Michael O'Riordan

August 26, 2024

News Daily News

Scientific Statement Reviews Current Antithrombotic Options in PAD

L.A. McKeown

August 26, 2024

News Daily News

COVID-19 Vaccination Tied to Fewer CV Events in Large UK Study

Todd Neale

August 01, 2024

News Daily News

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Michael O'Riordan

July 09, 2024

News Daily News

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

L.A. McKeown

February 13, 2024

News Daily News

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Shelley Wood

January 17, 2024

News Daily News

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Yael L. Maxwell

September 05, 2023

News Conference News SCAI 2023

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

L.A. McKeown

May 30, 2023

News Conference News EuroPCR 2023

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Todd Neale

May 18, 2023

News Daily News

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

L.A. McKeown

February 02, 2023

News Daily News

PREVENT CLOT Supports Aspirin for VTE Prevention in Trauma Fractures

L.A. McKeown

January 18, 2023

News Daily News

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Todd Neale

January 06, 2023

News Daily News

Top Policy and Practice News for Cardiologists in 2022

Caitlin E. Cox

January 02, 2023

Advertisement

For Monotherapy, P2Y12 Inhibitor Bests Aspirin After PCI for ACS: Meta-analysis

Fewer MACCE With P2Y12 Inhibitor vs Aspirin Monotherapy Over 5 Years

Patchy Anticoagulation Use During COVID Pandemic Raises Questions

Ischemic vs Bleeding Risks: Do Antiplatelet Guidelines Need Rethinking?

New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again

New Guidelines for CV Care in Patients Undergoing Noncardiac Surgery

ESC’s 2024 CCS Guidelines Embrace New Data, Smooth Old Tensions

AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients

Scientific Statement Reviews Current Antithrombotic Options in PAD

COVID-19 Vaccination Tied to Fewer CV Events in Large UK Study

Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF

Low Bleeding Profile With Asundexian Seen in Pooled Analysis

DOAC Don’ts: New Review Clarifies When Not to Use Direct Oral Anticoagulants

Unguided De-escalation, Short DAPT the Best Strategies in ACS: Meta-analysis

Thrombotic Risk Criteria Post-PCI for NSTE ACS Validated in New Analysis

ADALA: Low-Dose Apixaban Tops DAPT After LAA Closure

Sepsis Emerges as Powerful CVD Risk Factor in Large US Analysis

PREVENT CLOT Supports Aspirin for VTE Prevention in Trauma Fractures

CV Risk After Acute COVID-19 Not So High as Feared: Registry

Top Policy and Practice News for Cardiologists in 2022

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content